Pacific Biosciences of California, Inc.
PACBNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for PACB. That does not mean none is planned.
Get an email about PACB's next catalysts
Track Pacific Biosciences of California (PACB) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 1 past
No catalysts found.
Market Overview
Stock performance and key metrics
Pacific Biosciences of California, Inc. (a.k.a. PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.
WebsiteNo drugs found in this phase.
Frequently asked questions
When is Pacific Biosciences of California, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for Pacific Biosciences of California, Inc. (PACB) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PACB biotech catalysts?→
Add PACB to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Pacific Biosciences of California, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.